INDEGENE LIMITED Financial Ratios
INDGN · Healthcare · Current price ₹510.9
P/E ratio
30.7x
P/B ratio
4.0x
ROE
14.4%
ROCE
19.0%
Debt / Equity
0.05
Dividend yield
0.4%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 30.7x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 4.0x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 14.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 19.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.05 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with INDEGENE LIMITED's latest numbers.
INDEGENE LIMITED profitability
INDEGENE LIMITED generates a return on equity of 14.4% and a return on capital employed of 19.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.05 and a P/E of 30.7x, INDEGENE LIMITED is conservatively financed. Our overall business-quality score for the company is 4.6 / 10.
Understand the ratios
More on INDEGENE LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.